Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is
Top Biotech Stocks To Watch Now - August 12th - Stock Observer
PEOPLE's 100 Companies That Care in 2026
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
AbbVie Inc. $ABBV Shares Bought by Wedge Capital Management L L P NC
Tema ETFs LLC Acquires 3,956 Shares of AbbVie Inc. $ABBV - Markets Daily
Tema ETFs LLC Purchases 3,956 Shares of AbbVie Inc. $ABBV - Zolmax
Cardinal Capital Management Inc. Buys 21,206 Shares of AbbVie Inc. $ABBV
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
BNP Paribas Exane Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
Eli Lilly Beat Big and Raised Guidance. Wall Street Sees More Room to Run
FY2027 EPS Estimates for AbbVie Lowered by Erste Group Bank
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?
AbbVie Inc. $ABBV Position Cut by Handelsbanken Fonder AB
Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices | INN
KMG Fiduciary Partners LLC Cuts Stake in AbbVie Inc. $ABBV
E. Ohman J or Asset Management AB Buys 2,250 Shares of AbbVie Inc. $ABBV - Markets Daily
KMG Fiduciary Partners LLC Lowers Stake in AbbVie Inc. $ABBV - Stock Observer
Carolina Wealth Advisors LLC Purchases 7,626 Shares of AbbVie Inc. $ABBV
Generali Investments Management Co LLC Buys 2,671 Shares of AbbVie Inc. $ABBV - Stock Observer
Carolina Wealth Advisors LLC Buys 7,626 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Stock Holdings Reduced by Handelsbanken Fonder AB - Daily Political
Big pharma sues to block Illinois drug discount law
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer
AbbVie's (ABBV) Botox Just Got A Step Closer To A Fifth Use
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?
Sionna cystic fibrosis drug fails key trial, removing threat to Vertex
3 Beaten-Down Healthcare Stocks to Buy in August
Sapient Capital LLC Sells 8,705 Shares of AbbVie Inc. $ABBV
Promising Pharmaceutical Stocks To Watch Now - August 10th - Daily Political
Biotech Stocks To Keep An Eye On - August 10th - Daily Political
AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Brokerages
Promising Pharmaceutical Stocks To Follow Now - August 9th - Markets Daily
GoalVest Advisory LLC Sells 6,171 Shares of AbbVie Inc. $ABBV
Cardano Risk Management B.V. Buys 32,345 Shares of AbbVie Inc. $ABBV
Agate Pass Investment Management LLC Has $13.67 Million Stock Position in AbbVie Inc. $ABBV
AbbVie (NYSE:ABBV) Stock Price Down 1% - Here's What Happened - Zolmax
Healthcare Stocks To Consider - August 8th - Stock Observer
Biotech Stocks To Watch Now - August 8th - Stock Observer
MRA Advisory Group Purchases 5,215 Shares of AbbVie Inc. $ABBV
MRA Advisory Group Boosts Position in AbbVie Inc. $ABBV - Stock Observer
Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma
Exploring the mixed marketing authorisation pathway: a case study in ophthalmology
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's Changed
Westmount Partners LLC Sells 6,457 Shares of AbbVie Inc. $ABBV
Assenagon Asset Management S.A. Grows Position in AbbVie Inc. $ABBV
Czech National Bank Has $126.55 Million Stock Position in AbbVie Inc. $ABBV
ABBV: Future Returns Will Hinge On Apogee Respiratory Bet
St. Louis Financial Planners Asset Management LLC Takes $5.01 Million Position in AbbVie Inc. $ABBV - Daily Political
AbbVie (NYSE:ABBV) Trading Down 1% - What's Next?
Regenxbio Inc (RGNX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended into Q4 2027 on ...
M&A and AI power red-hot summer in dollars
The 6.4% Monthly Payer That Beat JEPI by 8 Points With No NAV Bleed
Sanders Morris Harris LLC Sells 18,921 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Hamlin Capital Management LLC - Markets Daily
NewEdge Advisors LLC Buys 5,648 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV is Hamlin Capital Management LLC's 7th Largest Position - Stock Observer
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now
AbbVie (NYSE:ABBV) Stock Price Down 2.5% - Here's What Happened - Markets Daily
Prediction: AbbVie Will End The Year at This Price
Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout
Canandaigua National Bank & Trust Co. Acquires New Stake in AbbVie Inc. $ABBV
AbbVie (NYSE:ABBV) Raised to "Buy" at Erste Group Bank - Daily Political
AbbVie (ABBV) Wins FDA Review For BOTOX Cosmetic In Jawline Treatment Push
ABBV Q2 Deep Dive: Immunology and Neuroscience Expansion Shape Outlook Amid Guidance Reset
Allergan Aesthetics Seeks Fifth FDA Approval For BOTOX Cosmetic In Facial Contouring
AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
AbbVie Inc. $ABBV is Meadowbrook Wealth Management LLC's 7th Largest Position - Zolmax
Neville Rodie & Shaw Inc. Sells 17,684 Shares of AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Holdings Trimmed by Meadowbrook Wealth Management LLC
UBRELVY® (ubrogepant) Recommended for Reimbursement by Canada's Drug Agency (CDA-AMC) for Acute Migraine Treatment
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
Best Biotech Stocks To Watch Today - August 4th - Daily Political
CX Institutional Decreases Position in AbbVie Inc. $ABBV
Edgestream Partners L.P. Sells 58,230 Shares of AbbVie Inc. $ABBV - Daily Political
Navigating evidence-based recommendations for the management of systemic sclerosis
AbbVie (NYSE:ABBV) Shares Down 2.5% - Here's What Happened
AbbVie's Growth Now Leans On A Single Molecule
What Are Wall Street Analysts' Target Price for AbbVie Stock?
AbbVie Earnings: Maintaining Our Fair Value Estimate Following a Steady Second Quarter | Morningstar
AbbVie (NYSE:ABBV) Given New $285.00 Price Target at Cantor Fitzgerald - Markets Daily
AbbVie News
Super Micro Stock Forecast 2026–2030: SMCI Targets, Scenarios and Risks
Dow Jones Forecast for 2026 and 2030: Could the Index Reach 75,000?
Latest news
Show more
Gold Price Today, August 13: Gold Climbs Above $4,400 as Cooler US CPI Cuts Fed Hike Bets
KOSPI Jumps Nearly 5% as SK Hynix Surges 7% and Asian Chip Rally Accelerates
Gold Price Today, August 12, 2026: XAU/USD Rises 0.5% Near $4,400 Ahead of US CPI
Oil Nears $90 as Fading U.S.-Iran Deal Hopes Renew Hormuz Supply Fears
